
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $412.3K | $369.8K | -- | -- | $7.9M | |
Revenue Growth (YoY) | -96.1% | -10.31% | -- | -- | -- | |
Cost of Revenues | $206.2K | $281.8K | -- | -- | $3.1M | |
Gross Profit | $206.2K | $88K | -- | -- | $4.8M | |
Gross Profit Margin | 50% | 23.8% | -- | -- | 60.36% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.5M | $18.1M | $461.5K | $16.3M | $30.6M | |
Other Inc / (Exp) | $10K | $123.8K | -- | -$45.6M | -$12.8M | |
Operating Expenses | $2.5M | $18.2M | $461.5K | $16.5M | $31.3M | |
Operating Income | -$2.3M | -$18.2M | -$461.5K | -$16.5M | -$26.5M | |
Net Interest Expenses | $637K | $1.2M | -- | -- | $562K | |
EBT. Incl. Unusual Items | -$2.9M | -$19.2M | -$461.5K | -$62M | -$39.9M | |
Earnings of Discontinued Ops. | $961.3K | $1.9M | -- | -$17.1M | -$1M | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$1.9M | -$17.3M | -$461.5K | -$62M | -$39.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$1.9M | -$17.3M | -$461.5K | -$79.1M | -$40.9M | |
Basic EPS (Cont. Ops) | -$16.57 | -$106.00 | -$1.08 | -$16.51 | -$2.65 | |
Diluted EPS (Cont. Ops) | -$16.57 | -$106.00 | -$1.08 | -$16.51 | -$2.65 | |
Weighted Average Basic Share | $122.7K | $166.4K | $428.6K | $4.8M | $15.5M | |
Weighted Average Diluted Share | $122.7K | $166.4K | $428.6K | $4.8M | $15.5M | |
EBITDA | -$2.2M | -$17.9M | -$461.5K | -$61.9M | -$38.3M | |
EBIT | -$2.3M | -$18M | -$461.5K | -$61.9M | -$38.7M | |
Revenue (Reported) | $412.3K | $369.8K | -- | -- | $7.9M | |
Operating Income (Reported) | -$2.3M | -$18.2M | -$461.5K | -$16.5M | -$26.5M | |
Operating Income (Adjusted) | -$2.3M | -$18M | -$461.5K | -$61.9M | -$38.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $172.7K | $343.1K | -- | -- | $13.6M | |
Revenue Growth (YoY) | -93.36% | 98.65% | -- | -- | -- | |
Cost of Revenues | $75.2K | $386.3K | -- | -- | $6M | |
Gross Profit | $97.5K | -$43.3K | -- | -- | $7.6M | |
Gross Profit Margin | 56.46% | -12.62% | -- | -- | 55.9% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.9M | $2.9M | $64.4K | $7.6M | $5.6M | |
Other Inc / (Exp) | -- | $91.6K | -- | -- | -$3.1M | |
Operating Expenses | $2.9M | $3M | $64.4K | $8M | $5.8M | |
Operating Income | -$2.8M | -$3.1M | -$64.4K | -$8M | $1.8M | |
Net Interest Expenses | $224.1K | $148.1K | -- | -- | $1.3M | |
EBT. Incl. Unusual Items | -$3M | -$3.1M | -$64.4K | -$8M | -$2.6M | |
Earnings of Discontinued Ops. | $578.1K | $31.2K | -- | -$1M | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$2.5M | -$3.1M | -$64.4K | -$8M | -$2.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$2.5M | -$3.1M | -$64.4K | -$9M | -$2.6M | |
Basic EPS (Cont. Ops) | -$20.57 | -$9.71 | -$0.15 | -$0.90 | -$3.49 | |
Diluted EPS (Cont. Ops) | -$20.57 | -$9.71 | -$0.15 | -$0.90 | -$3.49 | |
Weighted Average Basic Share | $122.7K | $330K | $428.6K | $10M | $26.8M | |
Weighted Average Diluted Share | $122.7K | $330K | $428.6K | $10M | $26.8M | |
EBITDA | -$2.8M | -$2.8M | -$64.4K | -$8M | $878K | |
EBIT | -$2.8M | -$3M | -$64.4K | -$8M | -$1.2M | |
Revenue (Reported) | $172.7K | $343.1K | -- | -- | $13.6M | |
Operating Income (Reported) | -$2.8M | -$3.1M | -$64.4K | -$8M | $1.8M | |
Operating Income (Adjusted) | -$2.8M | -$3M | -$64.4K | -$8M | -$1.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -$2M | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -$1.7M | -- | -- | -- | -- | |
Gross Profit | -$274.4K | $44.7K | $320K | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $4.8M | $18.1M | -$3.3M | $23.8M | $28.5M | |
Other Inc / (Exp) | $10K | $91.6K | -$131.1K | -$45.6M | -$15.9M | |
Operating Expenses | $4.8M | $18.3M | -$3.7M | $24.5M | $29.1M | |
Operating Income | -$5.1M | -$18.3M | $4M | -$24.5M | -$16.7M | |
Net Interest Expenses | $704.8K | $1.1M | -- | -- | $1.9M | |
EBT. Incl. Unusual Items | -$5.8M | -$19.2M | $4.1M | -$69.9M | -$34.5M | |
Earnings of Discontinued Ops. | $578.1K | $1.3M | -$48.9K | -$18.1M | -$300 | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$4.2M | -$17.9M | $2.6M | -$69.9M | -$34.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$4.2M | -$17.9M | $4.1M | -$88.1M | -$34.5M | |
Basic EPS (Cont. Ops) | -$35.43 | -$71.72 | $9.79 | -$158.39 | -$5.29 | |
Diluted EPS (Cont. Ops) | -$35.43 | -$71.72 | $9.79 | -$158.39 | -$5.29 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$5M | -$17.8M | $3.6M | -$69.8M | -$29.4M | |
EBIT | -$5.1M | -$18.1M | $3.9M | -$69.8M | -$32M | |
Revenue (Reported) | -$2M | -- | -- | -- | -- | |
Operating Income (Reported) | -$5.1M | -$18.3M | $4M | -$24.5M | -$16.7M | |
Operating Income (Adjusted) | -$5.1M | -$18.1M | $3.9M | -$69.8M | -$32M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $172.7K | $343.1K | -- | -- | $13.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $75.2K | $386.3K | -- | -- | $6M | |
Gross Profit | $97.5K | -$43.3K | -- | -- | $7.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.9M | $2.9M | $64.4K | $7.6M | $5.6M | |
Other Inc / (Exp) | -- | $91.6K | -- | -- | -$3.1M | |
Operating Expenses | $2.9M | $3M | $64.4K | $8M | $5.8M | |
Operating Income | -$2.8M | -$3.1M | -$64.4K | -$8M | $1.8M | |
Net Interest Expenses | $224.1K | $148.1K | -- | -- | $1.3M | |
EBT. Incl. Unusual Items | -$3M | -$3.1M | -$64.4K | -$8M | -$2.6M | |
Earnings of Discontinued Ops. | $578.1K | $31.2K | -- | -$1M | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$2.5M | -$3.1M | -$64.4K | -$8M | -$2.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$2.5M | -$3.1M | -$64.4K | -$9M | -$2.6M | |
Basic EPS (Cont. Ops) | -$20.57 | -$9.71 | -$0.15 | -$0.90 | -$3.49 | |
Diluted EPS (Cont. Ops) | -$20.57 | -$9.71 | -$0.15 | -$0.90 | -$3.49 | |
Weighted Average Basic Share | $122.7K | $330K | $428.6K | $10M | $26.8M | |
Weighted Average Diluted Share | $122.7K | $330K | $428.6K | $10M | $26.8M | |
EBITDA | -$2.8M | -$2.8M | -$64.4K | -$8M | $878K | |
EBIT | -$2.8M | -$3M | -$64.4K | -$8M | -$1.2M | |
Revenue (Reported) | $172.7K | $343.1K | -- | -- | $13.6M | |
Operating Income (Reported) | -$2.8M | -$3.1M | -$64.4K | -$8M | $1.8M | |
Operating Income (Adjusted) | -$2.8M | -$3M | -$64.4K | -$8M | -$1.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.9M | $2.8M | $79.9K | $13M | $5.2M | |
Short Term Investments | -- | $302.7K | -- | -- | -- | |
Accounts Receivable, Net | $33.5K | $430 | -- | -- | $12.3M | |
Inventory | -- | $18.7K | -- | -- | -- | |
Prepaid Expenses | $53.3K | $7.7M | -- | $164.4K | -- | |
Other Current Assets | -- | -- | -- | $171K | $317K | |
Total Current Assets | $2.2M | $10.8M | $79.9K | $13.5M | $18.3M | |
Property Plant And Equipment | $253.9K | $2.4M | -- | $28.9M | $136.3M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $180.7K | -- | -- | $3.2M | $1.8M | |
Total Assets | $2.7M | $13.2M | $1.8M | $45.7M | $156.6M | |
Accounts Payable | $599.5K | $801.8K | -- | $2.3M | $33.9M | |
Accrued Expenses | $1.6M | $2.2M | $2.2M | $201K | $748K | |
Current Portion Of Long-Term Debt | $2.5M | $2.5M | -- | -- | $12.6M | |
Current Portion Of Capital Lease Obligations | $108.7K | $34K | -- | $42K | $323K | |
Other Current Liabilities | $2.2M | $472K | -- | -- | $2.4M | |
Total Current Liabilities | $7.1M | $6M | $2.2M | $5.4M | $63M | |
Long-Term Debt | $2.3M | $2.9M | -- | -- | $32.6M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $9.5M | $9M | $2.2M | $5.5M | $103.8M | |
Common Stock | $370 | $840 | -- | $98K | $230K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -$6.8M | $4.2M | -$381.5K | $40.2M | $52.8M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -$12.5K | -- | -- | -- | -- | |
Total Equity | -$6.8M | $4.2M | -$381.5K | $40.2M | $52.8M | |
Total Liabilities and Equity | $2.7M | $13.2M | $1.8M | $45.7M | $156.6M | |
Cash and Short Terms | $1.9M | $3.1M | $79.9K | $13M | $5.2M | |
Total Debt | $4.8M | $5.4M | -- | -- | $45.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2.6M | $1.1M | $27K | $4M | $15M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | $120 | -- | -- | $16.9M | |
Inventory | $305.5K | $549.6K | -- | -- | $1.3M | |
Prepaid Expenses | $360.1K | $7.1M | $4.7M | $175.7K | -- | |
Other Current Assets | -- | -- | -- | -- | $507K | |
Total Current Assets | $3.3M | $8.7M | $4.8M | $6.2M | $71.9M | |
Property Plant And Equipment | $263.8K | $4.3M | $1.6M | $31.2M | $689.3M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | $14.2M | |
Total Assets | $3.7M | $13.1M | $6.5M | $46.5M | $775.4M | |
Accounts Payable | $3.4M | $932.5K | $3.6M | $3.6M | $25.1M | |
Accrued Expenses | -- | $2.4M | $3.3M | $1.5M | $16.3M | |
Current Portion Of Long-Term Debt | $2.5M | $2.5M | $6.4M | -- | -- | |
Current Portion Of Capital Lease Obligations | $108.7K | $35.3K | -- | $162.8K | $384K | |
Other Current Liabilities | -- | $463.7K | $485.7K | -- | $3.1M | |
Total Current Liabilities | $6.6M | $6.4M | $13.7M | $8.6M | $126.6M | |
Long-Term Debt | $2.6M | $2.6M | $149.9K | -- | $378.5M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $9.3M | $9.1M | $13.9M | $8.9M | $553.1M | |
Common Stock | $370 | $1.2K | $1.3K | $108.6K | $188.7M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | $1.7M | -- | -- | -- | $148.3M | |
Minority Interest, Total | -$12.5K | -- | -- | -- | -- | |
Total Equity | -$5.6M | $4M | -$7.4M | $37.7M | $222.3M | |
Total Liabilities and Equity | $3.7M | $13.1M | $6.5M | $46.5M | $775.4M | |
Cash and Short Terms | $2.6M | $1.1M | $27K | $4M | $15M | |
Total Debt | $5.1M | $5.1M | $6.5M | -- | $378.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$1.9M | -$17.3M | -$461.5K | -$62M | -$39.9M | |
Depreciation & Amoritzation | $24.2K | $117.9K | -- | $983.8K | -- | |
Stock-Based Compensation | $407.9K | $12.6M | -- | $2.9M | $8.4M | |
Change in Accounts Receivable | -$33.3K | $33K | -- | -- | -$12.3M | |
Change in Inventories | -$220.6K | -$18.7K | -- | -- | -- | |
Cash From Operations | -$1.1M | -$7M | -$160 | -$11.9M | -$9.3M | |
Capital Expenditures | $156.7K | $9.9M | -- | $21.5M | $29.2M | |
Cash Acquisitions | -- | -- | -- | -- | -$55.5M | |
Cash From Investing | -$156.7K | -$9.9M | -- | -$23.7M | -$83.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $347.5K | $197.7K | -- | -- | $47.3M | |
Long-Term Debt Repaid | -- | -- | -- | -$150K | -$5.5M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -$1.1M | -$5.3M | |
Cash From Financing | $347.5K | $17.8M | $80K | $48.6M | $84.9M | |
Beginning Cash (CF) | $2.8M | $1.9M | -- | $80K | $13M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$880K | $887.5K | $79.9K | $13M | -$7.8M | |
Ending Cash (CF) | $1.9M | $2.8M | $79.9K | $13M | $5.2M | |
Levered Free Cash Flow | -$1.2M | -$16.9M | -$200 | -$33.5M | -$38.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$2.5M | -$3.1M | -$64.4K | -$8M | -$2.6M | |
Depreciation & Amoritzation | $4.5K | $164.4K | -- | -- | -- | |
Stock-Based Compensation | $2.1M | $1.9M | -- | $2.1M | $1.3M | |
Change in Accounts Receivable | $33.5K | $310 | -- | -- | -$4.6M | |
Change in Inventories | -$68.3K | $1.9K | -- | -- | -$1.3M | |
Cash From Operations | -$1.2M | -$1.1M | -$80 | -$3.3M | $16.9M | |
Capital Expenditures | -- | $2.1M | -- | $78K | $15M | |
Cash Acquisitions | -- | -- | -- | -$9M | -$474.6M | |
Cash From Investing | -- | -$1.4M | -- | -$10.1M | -$528.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $349M | |
Long-Term Debt Repaid | -- | -$14K | -- | -- | -$3.2M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$336K | |
Other Financing Activities | -- | -- | -- | -- | -$16.8M | |
Cash From Financing | $1.9M | $886K | -- | $4.5M | $521.3M | |
Beginning Cash (CF) | $1.9M | $2.8M | $79.9K | $13M | $5.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $737.6K | -$1.7M | -$80 | -$9M | $9.8M | |
Ending Cash (CF) | $2.6M | $1.1M | $79.8K | $4M | $15M | |
Levered Free Cash Flow | -$1.2M | -$3.3M | -$100 | -$3.4M | $1.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$4.2M | -$17.9M | $2.6M | -$69.9M | -$34.5M | |
Depreciation & Amoritzation | $20.4K | $277.9K | -- | -- | -- | |
Stock-Based Compensation | $2.5M | $12.4M | -$1.9M | $5M | $7.6M | |
Change in Accounts Receivable | $41K | -$100 | -$300 | -- | -- | |
Change in Inventories | -$289K | $51.5K | -- | -- | -- | |
Cash From Operations | -$1.9M | -$6.9M | $1.1M | -$15.3M | $10.9M | |
Capital Expenditures | $156.1K | $12M | -$2.1M | $21.6M | $44.2M | |
Cash Acquisitions | -- | -- | -- | -$9M | -$521.1M | |
Cash From Investing | -$156.1K | -$11.3M | $1.4M | -$33.8M | -$601.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $2.3M | $16.7M | -$806K | $53M | $601.7M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $235.1K | -$1.5M | $1.7M | $4M | $10.9M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$2M | -$19M | $3.3M | -$36.9M | -$33.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$2.5M | -$3.1M | -$64.4K | -$8M | -$2.6M | |
Depreciation & Amoritzation | $4.5K | $164.4K | -- | -- | -- | |
Stock-Based Compensation | $2.1M | $1.9M | -- | $2.1M | $1.3M | |
Change in Accounts Receivable | $33.5K | $310 | -- | -- | -$4.6M | |
Change in Inventories | -$68.3K | $1.9K | -- | -- | -$1.3M | |
Cash From Operations | -$1.2M | -$1.1M | -$80 | -$3.3M | $16.9M | |
Capital Expenditures | -- | $2.1M | -- | $78K | $15M | |
Cash Acquisitions | -- | -- | -- | -$9M | -$474.6M | |
Cash From Investing | -- | -$1.4M | -- | -$10.1M | -$528.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $349M | |
Long-Term Debt Repaid | -- | -$14K | -- | -- | -$3.2M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$336K | |
Other Financing Activities | -- | -- | -- | -- | -$16.8M | |
Cash From Financing | $1.9M | $886K | -- | $4.5M | $521.3M | |
Beginning Cash (CF) | $1.9M | $2.8M | $79.9K | $13M | $5.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $737.6K | -$1.7M | -$80 | -$9M | $9.8M | |
Ending Cash (CF) | $2.6M | $1.1M | $79.8K | $4M | $15M | |
Levered Free Cash Flow | -$1.2M | -$3.3M | -$100 | -$3.4M | $1.9M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.